Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus
Open Access
- 1 January 2014
- journal article
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 6 (5) , 327-335-35
Abstract
Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes MellitusKeywords
This publication has 29 references indexed in Scilit:
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and miceDiabetologia, 2009
- Direct Control of Peripheral Lipid Deposition by CNS GLP-1 Receptor Signaling Is Mediated by the Sympathetic Nervous System and Blunted in Diet-Induced ObesityJournal of Neuroscience, 2009
- Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humansDiabetologia, 2006
- (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 DiabetesJournal of Medicinal Chemistry, 2004
- Enhancing Incretin Action for the Treatment of Type 2 DiabetesDiabetes Care, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- Insulin resistance and cardiovascular diseaseJournal of Clinical Investigation, 2000
- Management of Primary HyperlipidemiaNew England Journal of Medicine, 1995
- Management of Dyslipidemia in NIDDMDiabetes Care, 1990
- Recommendation for Strict Control of Plasma Triglyceride in Diabetic SubjectsDiabetes Care, 1988